Injecto Group A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmarkIFRS
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  13.5% 0.0% 5.2% 6.4% 2.9%  
Credit score (0-100)  18 0 41 36 57  
Credit rating  BB N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 61.2 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8

Net sales  100 0 224 136 100  
Gross profit  -2,385 0.0 -1,479 -3,026 -3,185  
EBITDA  -4,118 0.0 -3,042 -5,088 -4,408  
EBIT  -4,416 0.0 -5,651 -7,848 -7,290  
Pre-tax profit (PTP)  -4,399.1 0.0 -10,124.6 -13,943.3 -7,136.8  
Net earnings  -4,399.1 0.0 -10,124.6 -15,234.0 -7,136.8  
Pre-tax profit without non-rec. items  -4,399 0.0 -10,125 -13,943 -7,137  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8

Tangible assets total  14.0 0.0 185 128 427  
Shareholders equity total  3,196 0.0 25,314 38,458 55,466  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 450  
Balance sheet total (assets)  10,774 0.0 45,864 40,083 57,133  

Net Debt  -550 -1,209 -2,067 -802 -3,367  
 
See the entire balance sheet

Volume 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8

Net sales  100 0 224 136 100  
Net sales growth  0.0% -100.0% 0.0% -39.3% -26.6%  
Gross profit  -2,385 0.0 -1,479 -3,026 -3,185  
Gross profit growth  -24.2% 0.0% 0.0% -104.6% -5.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  10,774 0 45,864 40,083 57,133  
Balance sheet change%  7.1% -100.0% 0.0% -12.6% 42.5%  
Added value  -4,415.9 0.0 -5,651.5 -7,848.0 -7,290.1  
Added value %  -4,415.9% 0.0% -2,520.0% -5,762.5% -7,290.1%  
Investments  4,651 -5,010 37,085 -42,327 -2,582  

Net sales trend  0.0 -1.0 0.0 -1.0 -2.0  
EBIT trend  -4.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
EBITDA %  -4,118.2% 0.0% -1,356.4% -3,735.9% -4,408.4%  
EBIT %  -4,415.9% 0.0% -2,520.0% -5,762.5% -7,290.1%  
EBIT to gross profit (%)  185.2% 0.0% 382.2% 259.3% 228.9%  
Net Earnings %  -4,399.1% 0.0% -4,514.6% -11,185.8% -7,136.8%  
Profit before depreciation and extraordinary items %  -4,101.4% 0.0% -3,351.0% -9,159.2% -4,255.1%  
Pre tax profit less extraordinaries %  -4,399.1% 0.0% -4,514.6% -10,238.0% -7,136.8%  
ROA %  -40.3% 0.0% -11.9% -17.5% -13.7%  
ROI %  -44.8% 0.0% -12.2% -18.1% -14.1%  
ROE %  -82.7% 0.0% -40.0% -47.8% -15.2%  

Solidity 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
Equity ratio %  100.0% 0.0% 55.2% 95.9% 97.1%  
Relative indebtedness %  0.0% 0.0% 9,163.3% 1,192.7% 1,667.5%  
Relative net indebtedness %  -550.2% 0.0% 8,241.8% 603.9% -2,149.9%  
Net int. bear. debt to EBITDA, %  13.4% 0.0% 67.9% 15.8% 76.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 213.9%  

Liquidity 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
Quick Ratio  0.0 0.0 4.2 1.1 3.3  
Current Ratio  0.0 0.0 4.2 1.1 3.3  
Cash and cash equivalent  550.2 1,209.1 2,066.5 802.0 3,817.4  

Capital use efficiency 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
Trade debtors turnover (days)  1,642.5 0.0 1,155.7 2,271.8 38.6  
Trade creditors turnover (days)  54.6 0.0 60.5 91.5 54.2  
Current assets / Net sales %  1,756.0% 0.0% 2,165.5% 1,219.6% 5,048.0%  
Net working capital  1,756.0 0.0 3,710.2 186.6 3,510.7  
Net working capital %  1,756.0% 0.0% 1,654.4% 137.0% 3,510.7%  

Employee efficiency 
2019
2019/8
2020
N/A
2021
2021/8
2022
2022/8
2023
2023/8
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0